Analyst Consensus ?
ConsensusHold69 ratings
Bullish3449.3%
Neutral3043.5%
Bearish57.2%
1 unmapped firm rating excluded from the percentages.
NIKE, Inc. · NKE · FY2026 Q4 · Calendar Q2 2026
Nike Q4 FY2026: Tariff Recovery Boosts EPS, But FY27 Revenue Guidance Cut
Nike's Q4 was boosted by a one-time $986M tariff recovery that drove a large EPS beat, but the core business remains in transition. Performance categories delivered mid single-digit growth and market-share gains, while sportswear and Jordan streetwear saw double-digit sell-through declines. Management lowered FY27 revenue guidance to a low-to-mid single-digit decline, though gross margin expansion is expected. Shares rose 5% on the print.
Reported After market closeNYSEConsumer Cyclical
$63.71B market cap
100quality score
Company context
Snapshot as of publicationNIKE, Inc., through its various subsidiaries, operates as a global enterprise focused on the design, development, marketing, and sale of athletic footwear, apparel, equipment, and accessories for all ages and genders. Beyond its primary offerings, the company provides a range of athletic and casual footwear, clothing, and accessories under the notable Jumpman trademark. It also distributes a variety of casual sneakers, apparel, and accessories, featuring well-known brands like Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell. Under the NIKE brand itself, the company supplies a comprehensive line of performance sports gear and accessories, such as bags, socks, sports balls, eyewear, timepieces, digital devices, bats, gloves, and protective equipment. Additionally, NIKE sells various plastic products to other manufacturers.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.72
Consensus $0
EPS surprise
+554.5%
Reported versus consensus
Reported revenue
$10.97B
Consensus $10.85B
Revenue surprise
+1.1%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$43.55Current
$35Low
$94.26Average
$192High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 1, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 1, 2026 |
| Telsey Advisory Group | Market Perform | Market Perform | Maintain | Jul 1, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 1, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 1, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 1, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 1, 2026 |
| BTIG | Buy | Buy | Maintain | Jul 1, 2026 |
| BNP Paribas | Underperform | Underperform | Maintain | Jul 1, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 1, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 1, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 29, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jun 26, 2026 |
| Keybanc | Overweight | Downgrade | Jun 26, 2026 | |
| Deutsche Bank | Hold | Hold | Maintain | Jun 26, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 23, 2026 |
| Evercore ISI Group | In Line | Outperform | Downgrade | Jun 23, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jun 10, 2026 |
| HSBC | Hold | Buy | Downgrade | Apr 13, 2026 |
| Truist Securities | Buy | Buy | Maintain | Apr 1, 2026 |
| Needham | Hold | Buy | Downgrade | Jan 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 1, 2025 |
| TD Cowen | Buy | Hold | Upgrade | Sep 10, 2025 |
| Argus Research | Buy | Hold | Upgrade | Jul 1, 2025 |
| Williams Trading | Buy | Buy | Maintain | Apr 21, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 21, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Jun 28, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Jun 28, 2024 |
| DZ Bank | Buy | Hold | Upgrade | Dec 12, 2023 |
| Erste Group | Hold | Buy | Downgrade | Sep 8, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jul 25, 2023 |
| OTR Global | Mixed | Positive | Downgrade | Jun 20, 2023 |
| Daiwa Capital | Neutral | Neutral | Maintain | Mar 28, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 22, 2023 |
| Redburn Partners | Sell | Sell | Maintain | Mar 16, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 21, 2022 |
| Seaport Global | Neutral | Buy | Downgrade | Jun 22, 2022 |
| KGI Securities | Neutral | Outperform | Downgrade | May 23, 2022 |
| Pivotal Research | Buy | Buy | Maintain | Jun 25, 2021 |
| Susquehanna | Positive | Positive | Maintain | Jun 23, 2020 |
| Consumer Edge Research | Overweight | Overweight | Maintain | Dec 27, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Dec 10, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Sep 25, 2019 |
| Nomura | Buy | Buy | Maintain | Mar 22, 2019 |
| Macquarie | Outperform | Outperform | Maintain | Sep 26, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 24, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Sep 19, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Sep 19, 2018 |
| Canaccord Genuity | Buy | Hold | Upgrade | Sep 11, 2018 |
| PiperJaffray | Overweight | Neutral | Upgrade | Aug 20, 2018 |
| Buckingham Research | Neutral | Buy | Downgrade | Jun 22, 2018 |
| Buckingham | Neutral | Buy | Downgrade | Jun 22, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| B. Riley | Neutral | Neutral | Maintain | Mar 23, 2018 |
| CLSA | Underperform | Underperform | Maintain | Jan 19, 2017 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jan 19, 2017 |
| FBR Capital | Market Perform | Market Perform | Maintain | Sep 28, 2016 |
| DA Davidson | Buy | Buy | Maintain | Sep 28, 2016 |
| Brean Capital | Hold | Buy | Downgrade | Sep 28, 2016 |
| BB&T Capital | Buy | Hold | Upgrade | Oct 19, 2015 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 14, 2014 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Sep 26, 2014 |
| Janney Capital | Buy | Neutral | Upgrade | Sep 26, 2014 |
| ISI Group | Strong Buy | Strong Buy | Maintain | Mar 22, 2013 |
| Benchmark | Buy | Buy | Maintain | Jun 29, 2012 |
| McAdams Wright Ragen | Sell | Hold | Downgrade | Jun 22, 2012 |
| Auriga | Buy | Buy | Maintain | Mar 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $43.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Berenberg Bank | Nick Anderson | $49 | $44.09 | +12.5% | Jul 3, 2026 |
| UBS | Jay Sole | $48 | $42.86 | +10.2% | Jul 1, 2026 |
| Jefferies | Analyst unavailable | $75 | $42.54 | +72.2% | Jul 1, 2026 |
| Stifel Nicolaus | Analyst unavailable | $45 | $41.05 | +3.3% | Jul 1, 2026 |
| Wells Fargo | Analyst unavailable | $40 | $41.05 | -8.2% | Jul 1, 2026 |
| Barclays | Analyst unavailable | $52 | $41.05 | +19.4% | Jul 1, 2026 |
| Piper Sandler | Analyst unavailable | $45 | $41.05 | +3.3% | Jul 1, 2026 |
| Telsey Advisory | Christina Fernandez | $47 | $41.05 | +7.9% | Jul 1, 2026 |
| Bernstein | Analyst unavailable | $72 | $41.05 | +65.3% | Jul 1, 2026 |
| Guggenheim | Simon Siegel | $60 | $41.05 | +37.8% | Jul 1, 2026 |
| Deutsche Bank | Analyst unavailable | $43 | $40.79 | -1.3% | Jun 26, 2026 |
| Oppenheimer | Analyst unavailable | $60 | $40.9 | +37.8% | Jun 26, 2026 |
| Stifel Nicolaus | Analyst unavailable | $50 | $40.9 | +14.8% | Jun 26, 2026 |
| BTIG | Robert Drbul | $55 | $41.82 | +26.3% | Jun 25, 2026 |
| Industrial Alliance Securities | Analyst unavailable | $55 | $42.38 | +26.3% | Jun 24, 2026 |
| Goldman Sachs | Analyst unavailable | $46 | $43.19 | +5.6% | Jun 23, 2026 |
| Evercore ISI | Analyst unavailable | $46 | $43.19 | +5.6% | Jun 23, 2026 |
| UBS | Jay Sole | $50 | $44.32 | +14.8% | Jun 10, 2026 |
| RBC Capital | Analyst unavailable | $50 | $44.65 | +14.8% | Jun 10, 2026 |
| Goldman Sachs | Analyst unavailable | $52 | $43.46 | +19.4% | Jun 5, 2026 |
| UBS | Analyst unavailable | $54 | $43.62 | +24.0% | Jun 5, 2026 |
| Wells Fargo | Analyst unavailable | $45 | $44.41 | +3.3% | May 8, 2026 |
| Piper Sandler | Analyst unavailable | $50 | $42.96 | +14.8% | Apr 10, 2026 |
| Evercore ISI | Analyst unavailable | $69 | $51.37 | +58.4% | Mar 27, 2026 |
| BNP Paribas | Analyst unavailable | $35 | $57.01 | -19.6% | Mar 6, 2026 |
| KeyBanc | Analyst unavailable | $75 | $65.41 | +72.2% | Jan 22, 2026 |
| Truist Financial | Analyst unavailable | $69 | $65.42 | +58.4% | Jan 14, 2026 |
| Jefferies | Randal Konik | $110 | $65.92 | +152.6% | Jan 12, 2026 |
| Deutsche Bank | Analyst unavailable | $67 | $64.34 | +53.8% | Jan 8, 2026 |
| RBC Capital | Analyst unavailable | $78 | $64.53 | +79.1% | Jan 6, 2026 |
| Telsey Advisory | Analyst unavailable | $72 | $59.16 | +65.3% | Dec 19, 2025 |
| UBS | Jay Sole | $62 | $59.36 | +42.4% | Dec 19, 2025 |
| Stifel Nicolaus | Peter McGoldrick | $65 | $59.47 | +49.3% | Dec 19, 2025 |
| Truist Financial | Analyst unavailable | $70 | $65.63 | +60.7% | Dec 19, 2025 |
| Needham | Analyst unavailable | $68 | $65.63 | +56.1% | Dec 19, 2025 |
| Goldman Sachs | Brooke Roach | $77 | $65.63 | +76.8% | Dec 19, 2025 |
| Bernstein | Analyst unavailable | $85 | $65.63 | +95.2% | Dec 19, 2025 |
| Wells Fargo | Analyst unavailable | $65 | $65.63 | +49.3% | Dec 19, 2025 |
| Piper Sandler | Analyst unavailable | $75 | $65.63 | +72.2% | Dec 19, 2025 |
| Barclays | Adrienne Yih | $64 | $65.63 | +47.0% | Dec 19, 2025 |
| Goldman Sachs | Brooke Roach | $89 | $67.49 | +104.4% | Dec 15, 2025 |
| UBS | Christina Fernandez | $75 | $63.44 | +72.2% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $77 | $63.44 | +76.8% | Dec 9, 2025 |
| BTIG | Bob Drbul | $100 | $67.64 | +129.6% | Oct 14, 2025 |
| KeyBanc | Analyst unavailable | $90 | $74.2 | +106.7% | Oct 2, 2025 |
| Barclays | Adrienne Yih | $70 | $69.73 | +60.7% | Oct 1, 2025 |
| Morgan Stanley | Alex Straton | $72 | $69.73 | +65.3% | Oct 1, 2025 |
| Piper Sandler | Anna Andreeva | $84 | $69.73 | +92.9% | Oct 1, 2025 |
| Stifel Nicolaus | Analyst unavailable | $68 | $69.73 | +56.1% | Oct 1, 2025 |
| Goldman Sachs | Analyst unavailable | $85 | $69.24 | +95.2% | Sep 25, 2025 |
| UBS | Jay Sole | $71 | $72.1 | +63.0% | Sep 19, 2025 |
| Barclays | Analyst unavailable | $65 | $72.33 | +49.3% | Sep 18, 2025 |
| RBC Capital | Analyst unavailable | $90 | $72.33 | +106.7% | Sep 18, 2025 |
| Jefferies | Analyst unavailable | $115 | $78.38 | +164.1% | Aug 22, 2025 |
| UBS | Jay Sole | $63 | $72.04 | +44.7% | Jun 27, 2025 |
| Morgan Stanley | Analyst unavailable | $70 | $67.94 | +60.7% | Mar 21, 2025 |
| Piper Sandler | Anna Andreeva | $90 | $71.2 | +106.7% | Jan 10, 2025 |
| Griffin | Katherine Griffin | $90 | $82.37 | +106.7% | Oct 10, 2024 |
| Truist Financial | Joseph Civello | $97 | $82.45 | +122.7% | Oct 10, 2024 |
| Truist Financial | Joseph Civello | $83 | $89.13 | +90.6% | Oct 2, 2024 |
| UBS | Jay Sole | $82 | $89.13 | +88.3% | Oct 2, 2024 |
| Jefferies | Randal Konik | $85 | $89.44 | +95.2% | Sep 30, 2024 |
| RBC Capital | Piral Dadhania | $85 | $87.46 | +95.2% | Sep 25, 2024 |
| Morgan Stanley | Alex Straton | $82 | $87.46 | +88.3% | Sep 25, 2024 |
| Bank of America Securities | Lorraine Hutchinson | $104 | $85.97 | +138.8% | Sep 20, 2024 |
| BMO Capital | Simeon Siegel | $92 | $86.08 | +111.3% | Sep 20, 2024 |
| Piper Sandler | Anna Andreeva | $80 | $85.92 | +83.7% | Sep 20, 2024 |
| Truist Financial | Joseph Civello | $85 | $85.75 | +95.2% | Sep 20, 2024 |
| Robert W. Baird | Jonathan Komp | $110 | $80.98 | +152.6% | Sep 20, 2024 |
| Bernstein | Aneesha Sherman | $109 | $80.9 | +150.3% | Sep 19, 2024 |
| Barclays | Adrienne Yih | $84 | $80.64 | +92.9% | Sep 18, 2024 |
| Citigroup | Paul Lejuez | $102 | $77.74 | +134.2% | Sep 10, 2024 |
| HSBC | Erwan Rambourg | $95 | $81.02 | +118.1% | Sep 5, 2024 |
| Stifel Nicolaus | Jim Duffy | $79 | $84.05 | +81.4% | Aug 26, 2024 |
| Williams Trading | Sam Poser | $93 | $83.62 | +113.5% | Aug 16, 2024 |
| CFRA | Zachary Warring | $89 | $73.42 | +104.4% | Jul 12, 2024 |
| RBC Capital | Piral Dadhania | $75 | $76.83 | +72.2% | Jul 2, 2024 |
| Wells Fargo | Ike Boruchow | $86 | $75.37 | +97.5% | Jun 30, 2024 |
| Bernstein | Aneesha Sherman | $112 | $75.37 | +157.2% | Jun 29, 2024 |
| KGI Securities | Jenny Liu | $86 | $76.21 | +97.5% | Jun 28, 2024 |
| CFRA | Zachary Warring | $83 | $75.37 | +90.6% | Jun 28, 2024 |
| BMO Capital | Simeon Siegel | $100 | $75.37 | +129.6% | Jun 28, 2024 |
| HSBC | Erwan Rambourg | $90 | $94.19 | +106.7% | Jun 28, 2024 |
| Telsey Advisory | Christina Fernandez | $100 | $94.19 | +129.6% | Jun 28, 2024 |
| Robert W. Baird | Jonathan Komp | $100 | $94.19 | +129.6% | Jun 28, 2024 |
| Williams Trading | Sam Poser | $67 | $94.19 | +53.8% | Jun 28, 2024 |
| UBS | Jay Sole | $78 | $94.19 | +79.1% | Jun 28, 2024 |
| Morgan Stanley | Alex Straton | $79 | $94.19 | +81.4% | Jun 28, 2024 |
| Evercore ISI | Michael Binetti | $105 | $94.19 | +141.1% | Jun 28, 2024 |
| Stifel Nicolaus | Jim Duffy | $88 | $94.19 | +102.1% | Jun 28, 2024 |
| Oppenheimer | Brian Nagel | $120 | $95.57 | +175.5% | Jun 21, 2024 |
| Williams Trading | Sam Poser | $75 | $94.78 | +72.2% | Jun 20, 2024 |
| Barclays | Adrienne Yih | $109 | $94.78 | +150.3% | Jun 20, 2024 |
| Morgan Stanley | Alex Straton | $116 | $93.39 | +166.4% | Jun 17, 2024 |
| Evercore ISI | Michael Binetti | $110 | $93.66 | +152.6% | Jun 17, 2024 |
| Deutsche Bank | Krisztina Katai | $115 | $93.68 | +164.1% | Jun 12, 2024 |
| Goldman Sachs | Brooke Roach | $118 | $93.68 | +171.0% | Jun 12, 2024 |
| Wells Fargo | Ike Boruchow | $115 | $96.55 | +164.1% | Jun 10, 2024 |
| RBC Capital | Piral Dadhania | $100 | $91.4 | +129.6% | May 24, 2024 |
| BMO Capital | Simeon Siegel | $118 | $89.07 | +171.0% | Apr 5, 2024 |
| Barclays | Adrienne Yih | $114 | $93.75 | +161.8% | Mar 25, 2024 |
| CFRA | Zachary Warring | $95 | $93.86 | +118.1% | Mar 22, 2024 |
| CFRA | Zachary Warring | $95 | $93.86 | +118.1% | Mar 22, 2024 |
| Wells Fargo | Kate Fitzsimons | $120 | $93.86 | +175.5% | Mar 22, 2024 |
| UBS | Jay Sole | $125 | $93.86 | +187.0% | Mar 22, 2024 |
| Truist Financial | Beth Reed | $99 | $93.86 | +127.3% | Mar 22, 2024 |
| Stifel Nicolaus | Jim Duffy | $117 | $93.86 | +168.7% | Mar 22, 2024 |
| Jefferies | Randal Konik | $100 | $93.86 | +129.6% | Mar 22, 2024 |
| Piper Sandler | Abbie Zvejnieks | $98 | $93.86 | +125.0% | Mar 22, 2024 |
| Telsey Advisory | Christina Fernandez | $115 | $93.86 | +164.1% | Mar 22, 2024 |
| Bernstein | Aneesha Sherman | $120 | $93.86 | +175.5% | Mar 22, 2024 |
| Goldman Sachs | Brooke Roach | $120 | $93.86 | +175.5% | Mar 22, 2024 |
| Truist Financial | Joseph Civello | $111 | $100.26 | +154.9% | Mar 20, 2024 |
| Telsey Advisory | Christina Fernandez | $120 | $98.74 | +175.5% | Mar 18, 2024 |
| RBC Capital | Piral Dadhania | $110 | $100.34 | +152.6% | Mar 12, 2024 |
| UBS | Jay Sole | $138 | $100.18 | +216.9% | Mar 12, 2024 |
| Loop Capital Markets | Simeon Siegel | $118 | $108.99 | +171.0% | Dec 22, 2023 |
| Barclays | Adrienne Yih | $119 | $122.53 | +173.2% | Dec 21, 2023 |
| RBC Capital | Piral Dadhania | $127 | $121.35 | +191.6% | Dec 14, 2023 |
| Goldman Sachs | Brooke Roach | $139 | $115.64 | +219.2% | Dec 5, 2023 |
| Loop Capital Markets | Simeon Siegel | $110 | $97.57 | +152.6% | Oct 10, 2023 |
| Raymond James | Rick Patel | $121 | $89.6 | +177.8% | Sep 28, 2023 |
| Telsey Advisory | Cristina Fernández | $135 | $110.67 | +210.0% | Jun 30, 2023 |
| Deutsche Bank | Gabriella Carbone | $126 | $112.93 | +189.3% | Jun 29, 2023 |
| Wells Fargo | Kate Fitzsimons | $130 | $113.03 | +198.5% | Jun 29, 2023 |
| Morgan Stanley | Alex Straton | $130 | $110.17 | +198.5% | Jun 20, 2023 |
| Morgan Stanley | Alex Straton | $140 | $119.5 | +221.5% | Mar 22, 2023 |
| HSBC | Erwan Rambourg | $125 | $123.31 | +187.0% | Mar 21, 2023 |
| Credit Suisse | Kevin Mcveigh | $51 | $127.36 | +17.1% | Jan 12, 2023 |
| Cowen & Co. | Cowen Cowen | $131 | $117.01 | +200.8% | Jan 2, 2023 |
| Piper Sandler | John Barnidge Analyst | $106 | $116.25 | +143.4% | Dec 27, 2022 |
| BMO Capital | Simeon Siegel | $120 | $115.78 | +175.5% | Dec 22, 2022 |
| KeyBanc | Noah Zatzkin | $120 | $117.26 | +175.5% | Dec 21, 2022 |
| Deutsche Bank | Gabriella Carbone | $133 | $103.21 | +205.4% | Dec 21, 2022 |
| Morgan Stanley | Alex Straton | $127 | $112.13 | +191.6% | Dec 13, 2022 |
| Cowen & Co. | Cowen Cowen | $118 | $110.76 | +171.0% | Dec 1, 2022 |
| Morgan Stanley | Alex Straton | $120 | $85.1 | +175.5% | Sep 30, 2022 |
| Barclays | Adrienne Yih | $110 | $107.21 | +152.6% | Sep 20, 2022 |
| BNP Paribas | Sam Boughedda | $118 | $109.84 | +171.0% | Aug 9, 2022 |
| UBS | Jay Sole | $156 | $105 | +258.2% | Jul 26, 2022 |
| Morgan Stanley | Alex Straton | $149 | $107.93 | +242.1% | Jul 11, 2022 |
| Guggenheim | Robert Drbul | $155 | $101.18 | +255.9% | Jul 5, 2022 |
| Barclays | Adrienne Yih | $125 | $102.78 | +187.0% | Jun 29, 2022 |
| Telsey Advisory | Cristina Fernandez | $130 | $105.58 | +198.5% | Jun 28, 2022 |
| Telsey Advisory | Cristina Fernández | $140 | $105.37 | +221.5% | Jun 22, 2022 |
| Barclays | Adrienne Yih | $140 | $108.99 | +221.5% | Jun 21, 2022 |
| UBS | Jay Sole | $168 | $112.22 | +285.8% | Jun 15, 2022 |
| Guggenheim | Robert Drbul | $160 | $114.73 | +267.4% | Jun 13, 2022 |
| Wells Fargo | Kate Fitzsimons | $150 | $121.67 | +244.4% | Jun 7, 2022 |
| Stifel Nicolaus | Jim Duffy | $150 | $120.95 | +244.4% | Jun 6, 2022 |
| Wedbush | Tom Nikic | $139 | $113.01 | +219.2% | May 15, 2022 |
| Jefferies | Randal Konik | $185 | $133.05 | +324.8% | Apr 18, 2022 |
| Truist Financial | Beth Reed | $176 | $133.09 | +304.1% | Mar 22, 2022 |
| Telsey Advisory | Cristina Fernandez | $170 | $133.09 | +290.4% | Mar 22, 2022 |
| Evercore ISI | Omar Saad | $185 | $133.09 | +324.8% | Mar 22, 2022 |
| Morgan Stanley | Kimberly Greenberger | $192 | $133.09 | +340.9% | Mar 22, 2022 |
| Deutsche Bank | Gabriella Carbone | $175 | $133.09 | +301.8% | Mar 22, 2022 |
| Robert W. Baird | Jonathan Komp | $165 | $130.19 | +278.9% | Mar 21, 2022 |
| Goldman Sachs | Kate McShane | $177 | $130.19 | +306.4% | Mar 21, 2022 |
| J.P. Morgan | Matthew Boss | $164 | $130.19 | +276.6% | Mar 21, 2022 |
| Barclays | Adrienne Yih | $161 | $119.4 | +269.7% | Mar 15, 2022 |
| Bank of America Securities | Lorraine Hutchinson | $140 | $119.4 | +221.5% | Mar 15, 2022 |
| UBS | Jay Sole | $173 | $117.57 | +297.2% | Mar 14, 2022 |
| Bernstein | Aneesha Sherman | $160 | $117.57 | +267.4% | Mar 14, 2022 |
| HSBC | Erwan Rambourg | $140 | $122.63 | +221.5% | Mar 11, 2022 |
| Cowen & Co. | John Kernan | $144 | $126.03 | +230.7% | Mar 10, 2022 |
| Wells Fargo | Kate Fitzsimons | $175 | $145.91 | +301.8% | Jan 30, 2022 |
| Seaport Global | Mitch Kummetz | $175 | $146.62 | +301.8% | Jan 18, 2022 |
| Piper Sandler | Erinn Murphy | $183 | $146.62 | +320.2% | Jan 18, 2022 |
| Wedbush | Tom Nikic | $185 | $166.25 | +324.8% | Dec 21, 2021 |
| Oppenheimer | Brian Nagel | $195 | $164.15 | +347.8% | Jul 26, 2021 |
| Argus Research | John Staszak | $182 | $160.62 | +317.9% | Jul 14, 2021 |
Track every rating change on NKE the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
+4.9%
Event window
SPY move
-0.1%
Same window
Abnormal move
+5.0%
Stock minus SPY
Volume
3.1×
Versus trailing sessions
Subsequent drift
-0.9%
Up to 20 sessions
NKESPY benchmark
Follow NKE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue was flat YoY (down 1% reported, down 4% currency-neutral) at $10.97B, slightly above consensus. EPS of $0.72 crushed estimates, driven by a $986M tariff recovery benefit. Performance categories grew mid single digits with market-share gains in Western Europe. Wholesale rose 4% (10% in North America), including the first positive Foot Locker comp in over four years. Sportswear and Jordan streetwear sell-through remained down double digits. Shares jumped 5% on 3.1x volume.
Guidance delta
lowered
Key takeaways
- Performance categories (running, football, training) delivered mid single-digit growth and market-share gains, supported by World Cup marketing momentum.
- Sportswear and Jordan streetwear continue to face double-digit sell-through declines, prompting a product refresh with a dozen-plus new styles planned for FY27.
- A one-time $986M tariff recovery benefit boosted gross margin and EPS, but management flagged potential incremental tariff rates of 10%-15% ahead.
- Wholesale grew 4% overall with a 10% increase in North America, and Nike posted its first positive retail-sales comp with Foot Locker in over four years.
- FY27 revenue guidance was lowered to a low-to-mid single-digit decline, though gross margin expansion is expected.
Management priorities
- Launch more than a dozen new sportswear footwear styles in FY27 to reset the classic franchises.
- Elevate 50% of Nike Direct owned stores by end of FY27.
- Launch locally designed products in Greater China for Holiday '27 as part of the market reset.
- Roll out the next wave of performance innovations (Aerofit, Pegasus 42 extensions) in spring '27.
- Host an Investor Day in November to detail the next phase of the sport offense strategy.
Sources
- Earnings call transcript and parsed analysis · 2026-06-30T23:05:06.257855+00:00
- FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
- Polygon adjusted daily market bars · 2026-07-29T16:42:01.570151+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T16:42:01.567469+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.